A common chronic skin condition affecting 125 million people worldwide, psoriasis is an autoimmune disease, a class of disorders in which the immune system attacks the body's own healthy cells. In recent years, new medications—known as biologics—that inhibit the overactive immune system by targeting specific inflammatory pathways, have revolutionized the treatment of psoriasis and other autoimmune diseases. However, until now, few studies have documented the comparative safety of these various biologics.
* This article was originally published here
This Blog Is Powered By Life Technology™. Visit Life Technology™ At www.lifetechnology.com Subscribe To This Blog Via Feedburner / Atom 1.0 / RSS 2.0.
Sunday, 12 May 2019
Rideshare firms have snarled up San Francisco: study
The ride-hailing era ushered in by Uber and Lyft once promised to complement public transit, reduce car ownership and alleviate congestion.
* This article was originally published here
* This article was originally published here
How to tell whether machine-learning systems are robust enough for the real world
MIT researchers have devised a method for assessing how robust machine-learning models known as neural networks are for various tasks, by detecting when the models make mistakes they shouldn't.
* This article was originally published here
* This article was originally published here
Uber, Lyft losses keep competitors at bay
A fare war between Uber and Lyft has led to billions of dollars in losses for both ride-hailing companies as they fight for passengers and drivers.
* This article was originally published here
* This article was originally published here
Older fathers put health of partners, unborn children at risk, study finds
Men who delay starting a family have a ticking "biological clock"—just like women—that may affect the health of their partners and children, according to Rutgers researchers.
* This article was originally published here
* This article was originally published here
Artificial intelligence could prevent unneeded tests in patients with stable chest pain
Artificial intelligence (AI) could prevent unnecessary diagnostic tests in patients with stable chest pain, according to research presented today at ICNC 2019. A decision support system saved one hour of testing per patient.
* This article was originally published here
* This article was originally published here
Subscribe to:
Posts (Atom)